revealed 45-48,XY,i(17)(q10), -6, ?8, -14, -21, ?21[cp10] (Fig. 2) . ATRA based combination chemotherapy with Daunomycin was given. Patient was in morphological remission at day 28 of induction and at the end of first consolidation cycle. After completion of consolidation phase, patient received maintenance therapy and is doing well at a follow up of 4 months.
APL can have varied clinical and morphogenetic presentation. Besides the conventional reciprocal translocation t(15;17)(q22;q21) disrupting the PML and RARa genes, other chromosomal abnormalities such as t(11;17) (q23;q21), t(5;17)(q35;q12-21), t(11;17)(q13;q21) and der(17) are also observed in APL whereby RARa is fused to the PLZF, NPM, NuMA, and STAT5b genes, respectively. An isochromosome of the long arm of the derivative chromosome 17 is rarely observed in APL patients. However our case is further rare as no evidence for rearrangement of RARa was found. Only 3 such cases have been reported previously in literature [2] [3] [4] . Two of these three patients responded poorly to therapy and died within a year [2, 4] . The prognosis of third cases is not known [3] . Our case responded to standard doses of ATRA and BM was in morphological remission at day 45. Consolidation and maintenance was uneventful and is doing well on maintenance. The present case hence highlights the importance of immune-morphological and genetic basis of APL. These cases can still be managed by ATRA which shows that differentiation block by any molecular mechanism in APL can still be overcome by its therapeutic doses as in our case. Management and prognosis of such patients remains unknown as there is not much literature on management of such patients. The lack of independent prognostic value of additional chromosomal abnormalities in APL does not support the use of alternative therapeutic strategies when such abnormalities are found [5] . ATRA however remains the mainstay drug as in our case. These cases help our understanding of pathogenesis APL better. Absence of RARa transcript does not necessarily mean absence of APL. It definitely signifies an alternate mechanism of pathogenesis unknown still to us. 
